RN

Ratanala Neeraja

Active Director Director DIN 10662141
DIN 10662141 First appointment Jun 2024
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value •••• Premium profile

About Ratanala Neeraja

Data last updated:

Ratanala Neeraja is a Director at Galik Pharma Private Limited (since 2024). Galik Pharma Private Limited reported revenue of ₹4.7 Lakh (FY 2025).

DIN 10662141
Primary Designation Director
First Appointment 10 Jun 2024
Oldest Company Age 2 yrs
Largest company Galik Pharma Private Limited · ₹4.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Galik Pharma Private Limited U46497TS2024PTC186382
Director10 Jun 20242024₹4.7 Lakh (FY 2025)Active

Board colleagues of Ratanala Neeraja

NameDINCompanyDesignation
Goverdhan Reddy Arakala07747800Galik Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Galik Pharma Private Limited
Premium access

Shareholding and investment profile for Ratanala Neeraja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ratanala Neeraja

Ratanala Neeraja currently holds 1 directorship: Galik Pharma Private Limited (Director, since 10 Jun 2024, revenue ₹4.7 Lakh (FY 2025)).

Ratanala Neeraja was first appointed on 10 Jun 2024 as Director at Galik Pharma Private Limited.

The current boards of Ratanala Neeraja's companies include Goverdhan Reddy Arakala (Galik Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available